[1] Hoang B V, Lee J, Choi I J, et al. Effect of dietary vitamin C on gastric cancer risk in the Korean population[J]. World Journal of Gastroenterology, 2016, 22(27):6257-67.
[2] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J]. International Journal of Cancer, 2015, 136(5):E359-86.
[3] Wang F H, Shen L, Li J, et al. The Chinese Society of Cli-nical Oncology (CSCO):clinical guidelines for the diagnosis and treatment of gastric cancer[J]. Cancer Communications (Lond), 2019, 39(1):10.
[4] 梁晓, 张红梅. 胃癌影像学研究进展[J]. 中国医刊, 2015, 50(4):8-11. Liang X, Zhang H M. Progress in imaging research of gastric cancer[J].China Medical Journal,2015,50(4):8-11.
[5] Khoonsari M, Mohammad HAM, Ghavam R, et al. Clinical manifestations and diagnosis of nonalcoholic fatty liver disease[J]. Iranian Journal of Pathology, 2017, 12(2):99-105.
[6] 汪军虎, 曹利利, 陈小军. 胃超声造影对胃部疾病诊断价值的研究[J]. 中国医药导报, 2015, 12(35):165-168. Wang J H, Cao L L, Chen X J. The research of diagnose value for gastric diseases by gastric contrastenhanced ultrasonography[J]. China Medical Herald, 2015, 12(35):165-168.
[7] Ajani J A, D'Amico T A, Almhanna K, et al. Gastric can-cer, version 3.2016, NCCN clinical practice guidelines in oncology[J]. Journal of the National Comprehensive Can-cer Network, 2016, 14(10):1286-1312.
[8] Ahn H S, Lee H J, Hahn S, et al. Evaluation of the se-venth American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification[J]. Cancer, 2011, 117(12):2823-2824.
[9] 何丽娉, 刘怡, 黄敏, 等. 胃超声造影对胃癌术前诊断及T分期的价值分析[J]. 现代消化及介入诊疗, 2018, 23(3):357-359. He L P, Liu Y, Huang M, et al. Rstenhanced ultrasonography in preoperative diagnosis and T staging of gastric can-cer[J]. Modern Digestion & Intervention, 2018, 23(3):357-359.
[10] Roy R K, Hoppe M M, Srivastava S, et al. CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer[J]. Oncotarget, 2016, 7(34):55290-55301.
[11] 洪勇强, 战微微, 杨继东, 等. 超声双重造影在进展期胃癌诊断及疗效评估中的研究[J]. 中华全科医学, 2015, 13(1):97-99. Hong Y Q,Zhan W W,Yang J D,et al. Utility of double contrast-enhanced ultrasonography in diagnosis and treatment evaluation of advanced gastric carcinoma[J]. Chinese Journal of General Practice, 2015, 13(1):97-99.
[12] 黄永波, 张妍, 王峻. 磁共振扩散加权成像在胃癌筛查与诊断中的应用价值[J]. 中国药物与临床, 2016, 16(12):1756-1758. Huang Y B, Zhang Y, Wang J. Application value of diffusionweighted magnetic resonance imagine in gastric cancer screenning and diagnosis[J]. Chinese Remedies & Clinics, 2016, 16(12):1756-1758.
[13] 郭燕鑫, 徐张英. 胃超声造影与超声内镜对胃癌术前分期诊断对比研究[J]. 医学影像学杂志, 2017, 27(9):1832-1835. Guo Y X, Xu Z Y. Comparative study of gastric contrast enhanced ultrasonography and endoscopic ultrasonography in preoperative staging of gastric cancer[J]. Journal of Medical Imaging, 2017, 27(9):1832-1835.
[14] van Putten M, Verhoeven R H, van Sandick J W, et al. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer[J]. British Journal of Surgery, 2016, 103(3):233-241.
[15] 叶伟坚, 陈秋兰, 陈建羡. 胃超声造影对老年人胃癌术前TNM分期的临床应用价值[J]. 中国医学工程, 2014, 22(5):120-121. Ye W J, Chen Q L, Chen J X. Clinical value of gastric contrastenhanced ultrasonography in preoperative TNM sta-ging of elderly patients with gastric cancer[J]. Chinese Medical Engineering, 2014, 22(5):120-121.
[16] 李铭, 王蕾, 彭雪芳, 等. 胃窗超声造影对胃癌T分期诊断的临床意义分析[J]. 临床医学工程, 2017, 24(8):1067-1068. Li M, Wang L, Peng X F, et al. The clinical significance of oral contrast-enhanced ultrasonography in predicting T stage of gastric cancer[J]. China Medical Engineering, 2017, 24(8):1067-1068.
[17] 杨红梅, 赵小东, 饶静, 等. 超声造影在胃癌诊断中的应用价值[J]. 临床超声医学杂志, 2013, 15(10):701-703. Yang H M, Zhao X D, Rao J, et al. Application value of contrast-enhanced ultrasound in the diagnosis of gastric cancer[J]. Journal of Ultrasound in Clinical Medicine, 2013, 15(10):701-703. |